Photoacoustic and multispectral imaging to monitor foot wounds after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot device study uses photoacoustic imaging alongside multispectral (Kent) imaging to measure tissue perfusion in post-surgical foot wounds. Wound care decisions in enrolled patients will be guided by the imaging results, although neither technique is currently standard clinical care. The study aims to test feasibility, identify practical issues, and collect data on drop-off rates and variation in wound healing to inform larger trials. Data collected will help determine how well these imaging methods track perfusion changes and support clinical use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a chronic wound on the foot that is presumed to be due to arterial insufficiency.

Exclusion Criteria:

* Patients with a massive deep tissue infection.
* Patients with preexisting skin conditions, such as melanoma, psoriasis, in areas close to the wound(s).
* Noncompliant patients who do not adhere to care plans.
* Pregnant women.
* Adults unable to consent.

Where it's running

• UBMD Vascular Surgery
  Buffalo, New York, United States Recruiting

Study contacts

• Study coordinator: Jun Xia, Ph.D.
• Email: junxia@buffalo.edu
• Phone: 716-645-8628

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcutaneous and topical photobiomodulation for diabetic foot ulcers

  This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.

  Recruiting Phase 2 University of Nove de Julho · Teresina, Piauí · NCT07798960

• Single-layer placental graft plus standard care for stubborn diabetic foot ulcers

  This trial will try a single-layer placental-based graft together with usual wound care for adults whose diabetic foot ulcers did not heal after standard treatment in an earlier trial.

  Recruiting Phase 4 Applied Biologics, LLC · Hollywood, Florida · NCT07159282

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Evaluating a new placental-based treatment for diabetic foot ulcers

  This study is testing if a new placental treatment can help adults with hard-to-heal diabetic foot ulcers get better faster when used alongside regular care.

  Recruiting Applied Biologics, LLC · Clinton Township, Michigan · NCT06564831

• Using dehydrated human amnion membrane to treat nonhealing diabetic foot ulcers

  This study is testing if adding dehydrated human amnion membrane to regular care can help people with stubborn diabetic foot ulcers heal better.

  Recruiting Axolotl Biologix · Thousand Oaks, California · NCT06550596

• Evaluating new treatments for hard-to-heal diabetic foot ulcers

  This study is testing if new treatments using special placental products can help heal tough diabetic foot ulcers better than the usual care alone.

  Recruiting at 3 sites StimLabs · Omaha, Nebraska and 4 other locations · NCT06449638

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.